Richard Chadderton

About

Richard Chadderton is the Board Director at SoloHealth Inc. Richard Chadderton is also Vice President, Corporate Strategy at WellPoint. In this role, he is responsible for leading the team that develops, enables and monitors the long-term strategic plan for WellPoint as well as leading efforts focused on the development of new businesses that extend beyond WellPoint’s core business models today. In addition he has overall responsibility for WellPoint’s International strategy and China. Prior to joining WellPoint, Richard was mostly recently Vice President of Corporate Strategy at Pfizer Inc and previously served as Vice President of the Portfolio & Decision Analysis Group at Pfizer Inc. In these roles he was responsible for Corporate Strategic planning as well as providing portfolio management and resource allocation support across the enterprise. Before Pfizer, Richard trained in Medicine and Surgery in the UK, is a Fellow of the Royal College of Surgeons and holds an MBA. Richard

Investment Focus